<DOC>
	<DOCNO>NCT01123382</DOCNO>
	<brief_summary>Post-stroke shoulder pain major rehabilitation problem affect moderate severely impaired stroke survivor . Surface electrical stimulation ( ES ) muscle surround hemiparetic shoulder demonstrate beneficial , despite evidence therapeutic benefit , clinical implementation surface ES poststroke shoulder pain difficult . In order address limitation surface ES , investigative team pioneer development percutaneous intramuscular ( IM ) ES treatment post-stroke shoulder pain . However , prior acceptance clinical community , additional gap scientific clinical knowledge need address . This study begin . The primary objective estimate relative pain reduction associate IM ES vs. `` usual care . '' We hypothesize IM ES group exhibit large effect size respect pain reduction compare `` usual care '' . A secondary objective estimate effect health relate QOL IM ES vs. `` usual care . '' Demonstration improvement QOL validate clinical relevance intervention . We hypothesize IM ES group exhibit great improvement health relate QOL compare `` usual care '' .</brief_summary>
	<brief_title>Electrical Stimulation Hemiplegic Shoulder Pain</brief_title>
	<detailed_description />
	<mesh_term>Shoulder Pain</mesh_term>
	<criteria>shoulder pain localized glenohumeral joint , subacromial area deltoid insertion associate following condition : ) rest ; b ) passive abduction external rotation ROM ; c ) active abduction external rotation ROM ; ) manual palpation weakness shoulder abductor ( ≤4/5 MRC isolate movement present ) age ≥21yrs time stroke ≥ 3mo shoulder pain onset recent stroke duration shoulder pain ≥ 3mo severity shoulder pain BPISF 3 ≥4 cognitive ability fulfill study requirement [ ) exhibit 3 object immediate 30 minute recall ; b ) ability use numeric rating scale ( use 010 numeric rating scale ) correctly rank tightness feel unaffected arm 3 lowpressure inflation standard sphygmomanometer cuff follow predetermine sequence ( 20 , 40 0 mm Hg ) ; c ) ability follow 3stage command ] availability reliable adult check skin assist participant treatment protocol willing able report severity shoulder pain throughout study period willing make schedule study visit postimplantation . evidence joint overlie skin infection insensate skin &gt; 1 opioid nonopioid analgesic daily shoulder pain daily intake pain medication chronic pain intraarticular subacromial steroid injection shoulder previous 12wks botulinum toxin injection trapezius , pectoralis subscapularis muscle previous 12wks receive physical occupational therapy shoulder pain physiciandiagnosed shoulder pathology symptomatic within 5 yrs prior CVA bleed disorder INR &gt; 3.0 warfarin [ INR &gt; 3.0 ] poorly control diabetes [ HbA1c &gt; 7.0 ] medical instability pregnancy uncontrolled seizure ( &gt; 1/mo 6mo ) uncompensated hemineglect severely impaired communication moderate severe depression confound condition ipsilateral upper limb lower motorneuron lesion , Parkinson 's Disease , spinal cord injury , traumatic brain injury multiple sclerosis medical issue complex regional pain syndrome , bicipital tendonitis , myofacial pain syndrome , etc . follow cardiac condition : ) history arrhythmia hemodynamic instability , ventricular tachycardia , supraventricular tachycardia rapid ventricular response atrial fibrillation ; b ) implantable stimulator demand pacemaker defibrillator ; c ) valvular heart disease include artificial valve ( due risk infection endocarditis ) likely noncompliance factor distance center , inadequate social support , psychiatric/psychologic factor</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Shoulder pain</keyword>
	<keyword>Electrical stimulation</keyword>
	<keyword>Neuromuscular stimulation</keyword>
	<keyword>Intramuscular stimulation</keyword>
</DOC>